8-K: Healthcare Triangle Faces Nasdaq Delisting Warning

Healthcare Triangle, Inc. has received a delisting determination from Nasdaq due to non-compliance with the minimum bid price requirement, with a hearing requested.

Summary

• Healthcare Triangle, Inc. received a notice from Nasdaq on October 1, 2026, stating it is not in compliance with the minimum bid price requirement of $1.00 per share.
• The company is not eligible for a compliance period because it has executed reverse stock splits totaling a cumulative ratio of 1-for-14,940 over the prior two years.
• Nasdaq has issued a Staff Delisting Determination, meaning the company's securities are subject to delisting.
• Trading suspension and filing of Form 25-NSE to remove securities from Nasdaq are scheduled for October 12, 2026, unless an appeal is requested.
• The company intends to request a hearing before a Nasdaq Hearings Panel by October 8, 2026, to present a plan for continued listing.
• A hearing request will stay the suspension and delisting process pending the Panel's decision.
• There is no assurance the Panel will grant continued listing or that compliance will be achieved.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a negative development due to the company's non-compliance with Nasdaq listing rules and the potential for delisting.

Positives

• The company intends to request a hearing with the Nasdaq Hearings Panel, which will stay the suspension and delisting process pending a decision.
• The company plans to present a plan to regain compliance, which may include a reverse stock split.

Negatives

• The company is not in compliance with Nasdaq's minimum bid price requirement.
• The company is ineligible for a standard compliance period due to multiple reverse stock splits within the past two years.
• Nasdaq has issued a Staff Delisting Determination, placing the company's securities at risk of delisting.
• Trading suspension and delisting are scheduled to commence on October 12, 2026, if no appeal is filed.

Risks

• The primary risk is the delisting of the company's common stock from The Nasdaq Capital Market, which would significantly impact liquidity and investor confidence.
• Failure to regain compliance with the minimum bid price rule, even after a hearing, could lead to permanent delisting.
• The company's history of reverse stock splits indicates ongoing challenges in maintaining a sufficient stock price, potentially signaling underlying business issues.
• There is no guarantee that the Nasdaq Hearings Panel will grant the company's request for continued listing or allow additional time for compliance.

Future Outlook

The company's future outlook is uncertain as it faces potential delisting from Nasdaq. The company intends to appeal the delisting determination and present a plan to regain compliance, but there is no guarantee of success.

Management Comments

• The Company intends to timely request a hearing before the Panel pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series.
• In connection with the hearing, the Company intends to present a plan to regain compliance with the Bid Price Rule, which may include, among other things, effecting a reverse stock split, if necessary.
• There can be no assurance that the Panel will grant the Companys request for continued listing or that the Company will be able to regain compliance with the Bid Price Rule within any additional period of time that may be granted by the Panel.

Industry Context

StockSavvy.ai notes that Nasdaq's listing rules are designed to ensure a certain level of market capitalization and investor interest. Companies that repeatedly fail to meet these standards, particularly the minimum bid price, often face significant challenges in maintaining investor confidence and liquidity, which can be a precursor to more severe financial distress.

Stakeholder Impact

• Shareholders: Potential for reduced liquidity and difficulty trading shares if delisted from Nasdaq. Negative impact on share value due to delisting risk.
• Creditors: Increased risk of default if the company's financial situation deteriorates further due to delisting.
• Employees: Potential impact on morale and job security if the company faces severe financial distress.

Next Steps

• Request a hearing before the Nasdaq Hearings Panel by October 8, 2026.
• Present a plan to regain compliance with the Bid Price Rule to the Panel.
• Await the Panel's decision regarding continued listing.

Key Dates

Recommendation

The company is facing a delisting determination from Nasdaq due to non-compliance with minimum bid price rules, exacerbated by a history of reverse stock splits. This indicates significant underlying financial and operational challenges with no guarantee of resolution, making the stock a high-risk investment.

Keywords

Nasdaq delisting, minimum bid price, compliance, reverse stock split, Hearings Panel, listing standards, common stock, delisting determination